Anixa Biosciences's total assets for Q were $22.91M, a decrease of -5.94% from the previous quarter. ANIX total liabilities were $2.22M for the fiscal quarter, a 24.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.